Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |